An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Clinical trial NCT05183802 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05183802
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.